The blood test also had a sensitivity and specificity of 92.3% and 92.6% for participants who do not have breast cancer. The results were consistent for women with dense breast tissue and non-dense ...

The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, ...

A pioneering study has found that an individualized approach to breast cancer screening that assesses patients' risk, rather ...

New research indicates that personalized breast cancer screening based on individual risk could improve detection while reducing unnecessary testing. A new study suggests that tailoring breast cancer ...

Breast cancer comes with many variables. A pair of powerful genomic tests can help women and their care teams make personalized care decisions.

Coverage marks a pivotal step in expanding access to ultra-sensitive MRD detection for breast cancer patients U.S. Medicare coverage decision reflects published, peer-reviewed clinical data ...

Guardant360 CDx is approved to identify ESR1 mutations in advanced breast cancer, aiding treatment with Inluriyo. Inluriyo showed a 38% lower risk of disease progression in the EMBER-3 trial compared ...

Researchers are studying tests called liquid biopsies, which can provide vital information about cancer genes using only a blood sample. A blood test to find cancer even before it shows any symptoms ...

In honor of Breast Cancer Awareness Month, the TODAY show, with the help of breast cancer survivors Jill Martin and Sheryl Crow, hosted Pink Power, an event dedicated to encouraging viewers and fans ...